EDGAR Filing Documents for 0001811764-22-000010

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001811764-22-000010

Filing Date

2022-02-15

Accepted

2022-02-15 16:19:09

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	a424b3with8-k.htm	424B3	28249
2	GRAPHIC	image_0.jpg	GRAPHIC	7287
	Complete submission text file	0001811764-22-000010.txt		39442

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268

Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182

POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22639419
SIC: 2834 Pharmaceutical Preparations